サマリー

甲状腺未分化癌治療薬の世界市場 2022-2026 年
Technavioは甲状腺未分化癌治療薬市場を監視しており、2022-2026年の間に2億3053万ドルの成長が見込まれ、予測期間中にCAGR 5.44%で加速しています。当レポートでは、甲状腺未分化癌治療薬市場の全体分析、市場規模および予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、甲状腺がんの高い有病率、標的療法の導入、老年人口の増加によって牽引されています。
甲状腺未分化癌治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの甲状腺未分化癌治療薬市場は、以下のようにセグメント化されています。
製品別
- 化学療法
- 新規治療薬
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、甲状腺がんに対する意識の高まりが、今後数年間の甲状腺未分化がん治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、化学療法に対する強力なパイプラインと償還政策が、市場の大規模な需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細なイメージを提示します。甲状腺未分化癌治療薬市場に関する当レポートの対象領域は以下の通りです。
- 未分化甲状腺癌治療薬市場のサイジング
- 甲状腺未分化癌治療薬市場の予測
- 甲状腺未分化癌治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Akorn Inc.、Amneal Pharmaceuticals Inc、Bayer AG、Bristol Myers Squibb Co、Cipla Ltd、第一三共 Co., Ltd.など、いくつかの主要甲状腺未分化がん薬市場ベンダーについての詳細分析を提供している。(注)1.平成23年3月31日現在の株主名簿に記載又は記録された株主又は登録株式質権者であります。第一三共株式会社、Dr. Reddys Laboratories Ltd.、エーザイ株式会社、Exelixis Inc.、Hikma Pharmaceuticals Plc、Intas Pharmaceuticals Ltd.、Johnson and Johnson, Medtronic Plc, Merck KGaA, Novartis AG, Pfizer Inc, Sanofi, Sun Pharmaceutical Industries Ltd.Ltd.、Viatris Inc.などがあります。また、甲状腺未分化癌治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/anaplastic-thyroid-cancer-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Chemotherapy - Market size and forecast 2021-2026
o Exhibit 28: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
o 5.4 Novel therapy - Market size and forecast 2021-2026
o Exhibit 32: Chart on Novel therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Novel therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Novel therapy - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Novel therapy - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Italy - Market size and forecast 2021-2026
o Exhibit 62: Chart on Italy - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Italy - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Italy - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Bayer AG
o Exhibit 85: Bayer AG - Overview
o Exhibit 86: Bayer AG - Business segments
o Exhibit 87: Bayer AG - Key offerings
o Exhibit 88: Bayer AG - Segment focus
o 10.4 Bristol Myers Squibb Co.
o Exhibit 89: Bristol Myers Squibb Co. - Overview
o Exhibit 90: Bristol Myers Squibb Co. - Product / Service
o Exhibit 91: Bristol Myers Squibb Co. - Key offerings
o 10.5 Eisai Co. Ltd.
o Exhibit 92: Eisai Co. Ltd. - Overview
o Exhibit 93: Eisai Co. Ltd. - Business segments
o Exhibit 94: Eisai Co. Ltd. - Key offerings
o Exhibit 95: Eisai Co. Ltd. - Segment focus
o 10.6 Johnson and Johnson
o Exhibit 96: Johnson and Johnson - Overview
o Exhibit 97: Johnson and Johnson - Business segments
o Exhibit 98: Johnson and Johnson - Key news
o Exhibit 99: Johnson and Johnson - Key offerings
o Exhibit 100: Johnson and Johnson - Segment focus
o 10.7 Medtronic Plc
o Exhibit 101: Medtronic Plc - Overview
o Exhibit 102: Medtronic Plc - Business segments
o Exhibit 103: Medtronic Plc - Key news
o Exhibit 104: Medtronic Plc - Key offerings
o Exhibit 105: Medtronic Plc - Segment focus
o 10.8 Merck KGaA
o Exhibit 106: Merck KGaA - Overview
o Exhibit 107: Merck KGaA - Business segments
o Exhibit 108: Merck KGaA - Key news
o Exhibit 109: Merck KGaA - Key offerings
o Exhibit 110: Merck KGaA - Segment focus
o 10.9 Novartis AG
o Exhibit 111: Novartis AG - Overview
o Exhibit 112: Novartis AG - Business segments
o Exhibit 113: Novartis AG - Key offerings
o Exhibit 114: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 115: Pfizer Inc. - Overview
o Exhibit 116: Pfizer Inc. - Product / Service
o Exhibit 117: Pfizer Inc. - Key news
o Exhibit 118: Pfizer Inc. - Key offerings
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.12 Viatris Inc.
o Exhibit 123: Viatris Inc. - Overview
o Exhibit 124: Viatris Inc. - Business segments
o Exhibit 125: Viatris Inc. - Key offerings
o Exhibit 126: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Novel therapy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Novel therapy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Novel therapy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Novel therapy - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Italy - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Italy - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Bayer AG - Overview
Exhibits86: Bayer AG - Business segments
Exhibits87: Bayer AG - Key offerings
Exhibits88: Bayer AG - Segment focus
Exhibits89: Bristol Myers Squibb Co. - Overview
Exhibits90: Bristol Myers Squibb Co. - Product / Service
Exhibits91: Bristol Myers Squibb Co. - Key offerings
Exhibits92: Eisai Co. Ltd. - Overview
Exhibits93: Eisai Co. Ltd. - Business segments
Exhibits94: Eisai Co. Ltd. - Key offerings
Exhibits95: Eisai Co. Ltd. - Segment focus
Exhibits96: Johnson and Johnson - Overview
Exhibits97: Johnson and Johnson - Business segments
Exhibits98: Johnson and Johnson - Key news
Exhibits99: Johnson and Johnson - Key offerings
Exhibits100: Johnson and Johnson - Segment focus
Exhibits101: Medtronic Plc - Overview
Exhibits102: Medtronic Plc - Business segments
Exhibits103: Medtronic Plc - Key news
Exhibits104: Medtronic Plc - Key offerings
Exhibits105: Medtronic Plc - Segment focus
Exhibits106: Merck KGaA - Overview
Exhibits107: Merck KGaA - Business segments
Exhibits108: Merck KGaA - Key news
Exhibits109: Merck KGaA - Key offerings
Exhibits110: Merck KGaA - Segment focus
Exhibits111: Novartis AG - Overview
Exhibits112: Novartis AG - Business segments
Exhibits113: Novartis AG - Key offerings
Exhibits114: Novartis AG - Segment focus
Exhibits115: Pfizer Inc. - Overview
Exhibits116: Pfizer Inc. - Product / Service
Exhibits117: Pfizer Inc. - Key news
Exhibits118: Pfizer Inc. - Key offerings
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits123: Viatris Inc. - Overview
Exhibits124: Viatris Inc. - Business segments
Exhibits125: Viatris Inc. - Key offerings
Exhibits126: Viatris Inc. - Segment focus
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations